Search results - 8 results
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factorsBackgroundMethodsResultsConclusionDataSheet_1.docx
Publication Type: Peer reviewed scientific article Authors: Konnova, Angelina; De Winter, Fien H. R.; Gupta, Akshita; Verbruggen, Lise; Hotterbeekx, An; Berkell, Matilda; Teuwen, Laure-Anne; Vanhoutte, Greetje; Peeters, Bart; Raats, Silke; Massen, Isolde ...
Epidemiology of COVID-19 mortality in Belgium from wave 1 to wave 7 (March 2020 – 11 September 2022)
old for both sex). During wave 1, when testing capacity was limited and only severe and hospitalized patients were tested, it reached 11.3%. The risk of dying from COVID-19 was larger and consistent for ...
Epidémiologie de la mortalité COVID-19 en Belgique de la vague 1 à la vague 7 (mars 2020- 11 septembre 2022)
ans et 9,87 % au-delà de 85 ans pour les deux sexes). Au cours de la vague 1, lorsque la capacité de test était limitée et que seuls les patients graves et hospitalisés ont été testés, il a atteint ...
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with CancerPurpose:Experimental Design:Results:Conclusions:
Publication Type: Peer reviewed scientific article Authors: Debie, Yana; Van Audenaerde, Jonas R.M.; Vandamme, Timon; Croes, Lieselot; Teuwen, Laure-Anne; Verbruggen, Lise; Vanhoutte, Greetje; Marcq, Elly; Verheggen, Lisa; Le Blon, Debbie; Peeters, Bart; ...
Early high antibody-titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma.
the prospective multicentre DAWN-plasma trial, adult patients hospitalised with COVID-19 were randomised to 4 units of open-label convalescent plasma combined with standard of care (intervention group) ...
Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study.
elucidate the epidemiology and burden of disease of seasonal hCoVs OC43, NL63, and 229E in patients in primary care and hospitals in Belgium between 2015 and 2020. Methods: We retrospectively analysed data ...
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the DAWn-Plasma trial.
BACKGROUND: The COVID-19 pandemic has imposed an enormous burden on health care systems around the world. In the past, the administration of convalescent plasma of patients having recovered from SARS and severe ...
Infection COVID-19 chez les enfants en Belgique. Résultats de la surveillance laboratoire, données scolaires et surveillance clinique des patients hospitalisés, 18/03-28/06/2020
patients hospitalisés pour le COVID-19. En outre, la grande partie (81 %) des hospitalisations chez les enfants se sont déroulées sans complications graves (telles que pneumonie, surinfection bactérienne ou ...